Pieris Pharmaceuticals, Inc.
Palvella Therapeutics develops topical therapies using its QTORIN platform for rare skin diseases and vascular malformations.
DEF 14AAug 18Latest SEC filing, period to Sep 29
Aug 4Latest story
August 2026
June 2026
Sign in